Dextromethorphan Hydrobromide/Guaifenesin/Naproxen Sodium

氢溴酸右美沙芬/愈创甘油醚/萘普生钠

Report date: 2025/12/24 20:00:51
NME

Base Information

Drug NameDextromethorphan Hydrobromide/Guaifenesin/Naproxen Sodium
Drug Alias NameMucinex 12 Hr Cold & Fever Multi-symptom
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsGlutamate [NMDA] receptorCyclooxygenase-1Cyclooxygenase-2
Therapy Area/IndicationsHeadachePainFever +[4] 
Global Approved IndicationsHeadachePainFever +[4] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/12/22
Country/TerritoryUnited States
CombinationsYes Dextromethorphan HydrobromideGuaifenesinNaproxen Sodium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesRB Health US LLC
China Registration ClassN/A

Develop Information

Active CompaniesRB Health US LLC
Inactive CompaniesN/A
Active IndicationsHeadachePainFever +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A